WARNING: We do not support Internet Explorer. It is not secure and will not work correctly. Please come back using a newer web browser.


Nucleic Acid Amplification Assays for Molecular Hematopathology, 2nd Edition

This guideline addresses the performance and application of assays for gene rearrangement and translocations by both polymerase chain reaction (PCR) and reverse-transcriptase PCR techniques, and includes information on specimen collection, sample preparation, test reporting, test validation, and quality assurance.

This document is available in electronic format only.

Member price:

List Price:
Log in/sign up to see price and add to cart


Chairholder: Daniel E. Sabath, MD, PhD

Date of Publication: March 30, 2012

Order Code PDF: CLSI MM05A2E
ISBN Number: 1-56238-791-X

Order Code Print: print not available

Edition: Second

Pages: 108

CLSI MM05 Additional Details

If interested in ordering larger quantities of this document in print, please contact us here.

The U.S. Food and Drug Administration (FDA) has evaluated and recognized this approved-level consensus standard for use in satisfying a regulatory requirement.

This archived document is no longer being reviewed through the CLSI Consensus Document Development Process. However, this document is technically valid as of July 2021. Because of its value to the laboratory community, it is being retained in CLSI’s library.